6,031 filings
Page 15 of 100
6-K
GSK
GSK Plc
26 Sep 22
GSK Chief Financial Officer Succession
6:12am
6-K
GSK
GSK Plc
22 Sep 22
Us Fda Odac Review of Zejula Phase III Nova Trial
9:22am
6-K
GSK
GSK Plc
22 Sep 22
GSK and Spero Therapeutics Licence for Tebipenem
6:11am
6-K
GSK
GSK Plc
21 Sep 22
Director/pdmr Shareholding
6:56am
4
TBPH
Theravance Biopharma Inc
20 Sep 22
Change in insider ownership
4:16pm
SC 13D/A
TBPH
Theravance Biopharma Inc
20 Sep 22
Theravance Biopharma / GSK ownership change
4:12pm
25-NSE
GSK
GSK Plc
15 Sep 22
Exchange delisting
3:54pm
6-K
GSK
GSK Plc
13 Sep 22
Director/pdmr Shareholding
6:52am
6-K
GSK
GSK Plc
8 Sep 22
Director/pdmr Shareholding
8:37am
6-K
GSK
GSK Plc
6 Sep 22
GSK Provides Update on Fda Review of Daprodustat
10:07am
25-NSE
New York Stock Exchange LLC
1 Sep 22
Exchange delisting
11:56am
6-K
GSK
GSK Plc
1 Sep 22
Total Voting Rights
8:52am
6-K
GSK
GSK Plc
24 Aug 22
GSK Board Changes
6:47am
6-K
GSK
GSK Plc
22 Aug 22
Director/pdmr Shareholding
12:50pm
6-K
GSK
GSK Plc
17 Aug 22
Fda New Drug Application File Acceptance for MMB
6:11am
6-K
GSK
GSK Plc
17 Aug 22
Statement: Zantac (Ranitidine) Litigation Update
6:04am
6-K
GSK
GSK Plc
16 Aug 22
GSK Completes Acquisition of Affinivax, Inc.
6:17am
6-K
GSK
GSK Plc
12 Aug 22
Statement: Zantac (Ranitidine) Litigation
6:18am
6-K
GSK
GSK Plc
11 Aug 22
Director/pdmr Shareholding
7:27am
6-K
GSK
GSK Plc
10 Aug 22
Director/pdmr Shareholding
1:41pm